文献速递垂体与肾上腺疾病性腺与生殖内分泌

唾液肾上腺特异性雄激素作为21-羟化酶缺乏症治疗控制生物标志物的测量

Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

结果显示血浆与唾液17OHP、A4、T、11OHA4和11KT均呈强相关,提示唾液肾上腺特异性雄激素可作为CAH无创监测策略。

要点

  • 血浆与唾液11KT、17OHP、A4等类固醇浓度呈强相关。
  • 唾液肾上腺特异性雄激素可用于CAH治疗控制的无创监测。
  • 相关性在基于性别和年龄的患者亚组中一致。

核心结论

  • 血浆与唾液肾上腺来源的11-氧合C19雄激素11KT以及17OHP和A4呈紧密相关,联合检测可作为CAH无创监测的改进唾液试验。

研究设计与样本

  • 前瞻性横断面研究,2015至2018年招募,英国13个三级中心参与。
  • 采用液相色谱-串联质谱法测量血浆和唾液五种类固醇浓度。

主要发现

  • CAH患者血浆与唾液17OHP强相关(rs=0.871;P<0.001)。
  • CAH患者血浆与唾液A4强相关(rs=0.931;P<0.001)。
  • CAH患者血浆与唾液T强相关(rs=0.867;P<0.001)。
  • CAH患者血浆与唾液11OHA4强相关(rs=0.876;P<0.001)。
  • CAH患者血浆与唾液11KT强相关(rs=0.944;P<0.001)。

临床怎么用

  • 唾液肾上腺特异性雄激素检测有望作为CAH患者疾病监测的无创策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monitoring of hormonal control represents a key part of the management of congenital adrenal hyperplasia (CAH). Monitoring strategies remain suboptimal because they rely on frequent blood tests and are not specific for adrenal-derived hormones. Recent evidence suggests the crucial role of adrenal-specific 11-oxygenated-C19 androgens in the pathogenesis of CAH. OBJECTIVE: To establish a correlation between plasma and salivary adrenal-specific androgens in CAH as a noninvasive monitoring strategy. DESIGN: This prospective cross-sectional study recruited patients between 2015 and 2018. SETTING: Multicenter study including 13 tertiary centers in the United Kingdom. PARTICIPANTS: Seventy-eight children with CAH and 62 matched healthy controls. METHODS: Using liquid chromatography-tandem mass spectrometry, plasma and salivary concentrations of five steroids were measured: 17-hydroxyprogesterone (17OHP), androstenedione (A4), testosterone (T), 11-hydroxyandrostenedione (11OHA4), and 11-ketotestosterone (11KT). The correlation between plasma and salivary steroids was analyzed to assess their use in clinical practice. RESULTS: Strong correlations between plasma and salivary steroid concentrations in patients with CAH were detected: 17OHP (rs = 0.871; P < 0.001), A4 (rs = 0.931; P < 0.001), T (rs = 0.867; P < 0.001), 11OH4A (rs = 0.876; P < 0.001), and 11KT (rs = 0.944; P < 0.001). These results were consistent for patient subgroups based on sex and age. Analysis of patient subgroups based on 17OHP concentrations established clear correlations between plasma and salivary concentrations of the adrenal-specific androgen 11KT. CONCLUSIONS: The current study identified tight correlations between plasma and saliva for the adrenal-derived 11-oxygenated C19 androgen 11KT, as well as 17OHP and A4, which are widely used for monitoring treatment in CAH. This combination of steroid hormones will serve as an improved noninvasive salivary test for disease monitoring in patients with CAH.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bacila I, Adaway J, Hawley J, et al. Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2019. PMID: 31361321. doi:10.1210/jc.2019-00031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。